© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.
ASCO endorses the following recommendations on ovarian ablation from Cancer Care Ontario:
- Ovarian ablation should not routinely be used with chemotherapy, tamoxifen, or a combination of these treatments.
- Ovarian ablation should not be used as an alternative to other treatments, unless a patient is not healthy enough for other treatments or if the patient chooses not to have other treatments.
- If ovarian ablation is chosen, monthly injections with an LHRH analogue is the best method. (ASCO's endorsement of this recommendation notes that treatment every three months may also be effective.)